AntiobesityResearch.com

Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006 Aug 24;355(8):763-78.

Aronne LJ, Thornton-Jones ZD. New targets for obesity pharmacotherapy. Clin Pharmacol Ther. 2007 May;81(5):748-52.          

Bessesen DH. Update on obesity. J Clin Endocrinol Metab. 2008 Jun;93(6):2027-34.

Byers T. Overweight and mortality among baby boomers--now we're getting personal. N Engl J Med. 2006 Aug 24;355(8):758-60

Clapham JC, Arch JR. Thermogenic and metabolic antiobesity drugs: rationale and opportunities. Diabetes Obes Metab. 2007 May;9(3):259-75.

Cree MG, Wolfe RR. Postburn trauma insulin resistance and fat metabolism. Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E1-9

Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome.. 2006 Dec 14;444(7121):881-7.

Dhillo WS. Appetite regulation: an overview. Thyroid. 2007 May;17(5):433-45.

Fernstrom JD, Choi S. The development of tolerance to drugs that suppress food intake. Pharmacol Ther. 2008 Jan;117(1):105-22.

Giugliano D, Ceriello A, Esposito K. Are there specific treatments for the metabolic syndrome? Am J Clin Nutr. 2008 Jan;87(1):8-11.

Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007 Feb;92(2):399-404.

Hansen MK, Connolly TM. Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis. Curr Opin Investig Drugs. 2008 Mar;9(3):247-55.

Hofbauer KG, Nicholson JR, Boss O. The obesity epidemic: current and future pharmacological treatments. Annu Rev Pharmacol Toxicol. 2007;47:565-92.

Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006 Dec 14;444(7121):860-7.

Ioannides-Demos LL, Proietto J, McNeil JJ. Pharmacotherapy for obesity. Drugs. 2005;65(10):1391-418.

Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006 Dec 14;444(7121):840-6.

Kushner RF. Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50

Lee S, Muniyappa R, Yan X, Chen H, Yue LQ, Hong EG, Kim JK, Quon MJ. Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E261-70.

Leslie WS, Hankey CR, Lean ME. Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. QJM. 2007 Jul;100(7):395-404.

Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E15-26.

Nisoli E, Carruba MO. Emerging aspects of pharmacotherapy for obesity and metabolic syndrome. Pharmacol Res. 2004 Nov;50(5):453-69

Pischon T, Boeing H, Hoffmann K, Bergmann M, et al.General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008 Nov 13;359(20):2105-20.

Segura J, Ruilope LM. Obesity, essential hypertension and renin-angiotensin system. Public Health Nutr. 2007 Oct;10(10A):1151-5

Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.N Engl J Med. 2008 Jul 17;359(3):229-41.

Staten MA. Challenges in the discovery and development of new agents for the treatment of obesity. Clin Pharmacol Ther. 2007 May;81(5):753-5.

Tschšp M, Thomas G. Fat fuels insulin resistance through Toll-like receptors. Nat Med. 2006 Dec;12(12):1359-61.

Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006 Dec 14;444(7121):875-80.

Vincent RP, le Roux CW. New agents in development for the management of obesity. Int J Clin Pract. 2007 Dec;61(12):2103-12.

Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, Hesson LA, Osei SY, Kaplan R, Stunkard AJ.Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005 Nov 17;353(20):2111-20.

Wisse BE, Kim F, Schwartz MW. Physiology. An integrative view of obesity. Science. 2007 Nov 9;318(5852):928-9

Chaston TB, Dixon JB, O'Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond). 2007 May;31(5):743-50.

Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, RodŽs-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49.

Fujimoto WY, Jablonski KA, Bray GA, Kriska A, at al. Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes. 2007 Jun;56(6):1680-5.

Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci. 2008;1129:287-304.

Livingston EH. Lower body subcutaneous fat accumulation and diabetes mellitus risk. Surg Obes Relat Dis. 2006 May-Jun;2(3):362-8

Redman LM, Ravussin E. Endocrine alterations in response to calorie restriction in humans. Mol Cell Endocrinol. 2009 Feb 5;299(1):129-36

Boling CL, Westman EC, Yancy WS. Comparison of weight-loss diets. N Engl J Med. 2009 May 21;360(21):2247

Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity: what fits whom? Diabetes Care. 2008 Feb;31 Suppl 2:S269-77.

Johnstone AM, Horgan GW, Murison SD, Bremner DM, Lobley GE. Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Am J Clin Nutr. 2008 Jan;87(1):44-55.

Johnstone AM. Fasting - the ultimate diet? Obes Rev. 2007 May;8(3):211-22.

Lechleitner M. Obesity and the metabolic syndrome in the elderly--a mini-review. Gerontology. 2008;54(5):253-9.

Mello MM. New York City's war on fat. N Engl J Med. 2009 May 7;360(19):2015-20.

Nourshahi M, Ahmadizad S, Nikbakht H, Heidarnia MA, Ernst E. The effects of triple therapy (acupuncture, diet and exercise) on body weight: a randomized, clinical trial.  Int J Obes (Lond). 2009 May;33(5):583-7.

Gummesson A, JernŒs M, Svensson PA, Larsson I, Glad CA, SchŽle E, Gripeteg L, Sjšholm K, Lystig TC, Sjšstršm L, Carlsson B, Fagerberg B, Carlsson LM. Relations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies. J Clin Endocrinol Metab. 2007 Dec;92(12):4759-65.

Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity: what fits whom? Diabetes Care. 2008 Feb;31 Suppl 2:S269-77.

Halford JC, Cooper GD, Dovey TM. The pharmacology of human appetite expression. Curr Drug Targets. 2004 Apr;5(3):221-40.

Haslam DW, James WP. Obesity. Lancet. 2005 Oct 1;366(9492):1197-209.

Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007 May;132(6):2087-102.

Rahman S, Scobie AI, Elkalaawy M, Bidlake LE, Fiennes AG, Batterham RL. Can glucose make you faint? Lancet. 2008 Oct 11;372(9646):1358.

Thaler JP, Cummings DE. Metabolism: food alert. Nature. 2008 Apr 24;452(7190):941-2.

Villareal DT, Apovian CM, Kushner RF, Klein S . Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res. 2005 Nov;13(11):1849-63.

Villareal DT, Banks MR, Patterson BW, Polonsky KS, Klein S. Weight loss therapy improves pancreatic endocrine function in obese older adults. Obesity (Silver Spring). 2008 Jun;16(6):1349-5

Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005 May;115(5):1111-9.